GreenLight and US NIH partner to develop Covid-19 vaccine for variants
The parties aim to manufacture vaccines with lasting immune responses compared to existing ones.

The parties aim to manufacture vaccines with lasting immune responses compared to existing ones.
The initial 66 million vaccine doses are anticipated to be supplied this year.
Despite the need, children with autism spectrum disorder are left with few difficult-to-administer off-label medications to treat agitation.
ByCAMP4 Therapeutics’ $100 million Series B supports clinical trial plans for urea cycle disorder program in 2023.
ByIn Q2 2022, the reported diluted EPS stood at $1.73 as against $0.98 in the year-ago quarter, indicating a 77%…
The BLA is based on positive data from various studies of N-803, including the Phase II/III QUILT 3.032 trial.
The alliance intends to unlock intractable drug targets and discover new therapies for human diseases.
Revenues grew 12% to $8.3bn in the US for the three months ended on 30 June.
Thank you for subscribing to Pharmaceutical Technology